0 Yorum
0 Paylar
102 Görüntüleme
Arama
Yeni insanlar keşfedin, yeni bağlantılar kurun ve yeni arkadaşlar edinin
-
Haber Akışı
- KEŞFEDIN
-
Sayfalar
-
Gruplar
-
Etkinlikler
-
Bloglar
-
Beğenmek, paylaşmak ve yorum yapmak için lütfen giriş yapın!
-
Asia Pacific Biologics Contract Manufacturing Market Poised for Strong Growth as Vaccine Manufacturing, Biosimilars, and Digital Technologies Accelerate DemandThe Asia Pacific biologics contract manufacturing market is entering a high-growth phase, supported by rising biopharmaceutical demand, expanding biologics pipelines, and increasing outsourcing among small and virtual biotechnology companies. According to Transparency Market Research, the market is projected to reach US$9.8 billion by 2031, expanding at a 14.5% CAGR from 2021 to 2031. Growing...0 Yorum 0 Paylar 181 Görüntüleme
-
Herceptin Biosimilars Market Size, Share, Trends, Industry Growth and Forecast by 2033"Executive Summary Herceptin Biosimilars Market Size and Share Across Top Segments CAGR Value Data Bridge Market Research analyses that the market which was USD 1,810 million in 2022, would rocket up to USD 11,302 million by 2030 and is expected to undergo a CAGR of 23.2% during the forecast period. To better structure this Herceptin Biosimilars report, a nice blend of...0 Yorum 0 Paylar 617 Görüntüleme
-
Oncology Biosimilars Market Growth Analysis by Product, Application and Region"Oncology Biosimilars Market Summary According to the latest report published by Data Bridge Market Research, the Oncology Biosimilars Market Global oncology biosimilars market size was valued at USD 6.66 billion in 2024 and is projected to reach USD 25.88 billion by 2032, with a CAGR of 18.5% during the forecast period of 2025 to 2032. An influential Oncology Biosimilars...0 Yorum 0 Paylar 301 Görüntüleme
-
Ophthalmology Anti-VEGF Biosimilars Market Shares, Demand, and Growth Trends 2033"Executive Summary Ophthalmology Anti-VEGF Biosimilars Market: Share, Size & Strategic Insights CAGR Value The global ophthalmology Anti-VEGF biosimilars market size was valued at USD 475.2 Million in 2025 and is expected to reach USD 958.74 Million by 2033, at a CAGR of 9.17% during the forecast period The Ophthalmology Anti-VEGF Biosimilars...0 Yorum 0 Paylar 726 Görüntüleme
-
Ophthalmology Anti-VEGF Biosimilars Market Size, Share, Trends, Industry Growth and Forecast to 2033"Ophthalmology Anti-VEGF Biosimilars Market Summary: According to the latest report published by Data Bridge Market Research, the Ophthalmology Anti-VEGF Biosimilars Market CAGR Value The global ophthalmology Anti-VEGF biosimilars market size was valued at USD 475.2 Million in 2025 and is expected to reach USD 958.74 Million by 2033, at a CAGR...0 Yorum 0 Paylar 440 Görüntüleme
-
Recombinant Hormone Biosimilars Market Innovation Trends Unlocking Long-Term Growth Potential" According to the latest report published by Data Bridge Market Research, the Recombinant Hormone Biosimilars Market The global recombinant hormone biosimilars market size was valued at USD 217.80 million in 2025 and is expected to reach USD 460.12 million by 2033, at a CAGR of 9.80% during the forecast period An international Recombinant Hormone...0 Yorum 0 Paylar 366 Görüntüleme
-
Biosimilars Market Trends: Why Patent Expirations Are Creating New Opportunities for Biosimilar DrugsBiosimilars Market: Interchangeability, Patent Expiry and the Checkpoint Inhibitor Pipeline The Biosimilars Market comprises biological medicines shown to be highly similar to an already approved reference biologic, with no clinically meaningful differences in safety, purity or potency. In the US, they are approved through the abbreviated 351(k) pathway established under the Biologics Price...0 Yorum 0 Paylar 65 Görüntüleme
Sponsor
